Bone marrow biopsy did not show JAK2, CALR or MPL mutations and there was no typical myelofibrosis or abnormal megakaryocyte hyperplasia, which excludes the possibility of myeloproliferative neoplasms. The gene discussed is JAK2; the disease is myeloproliferative neoplasm.